Morningstar24 天
Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment ...
HANGZHOU, China, March 9, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic ...